| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |